Schedule 13D ownership disclosure
Keenova Therapeutics PLC
Security class unavailable · CUSIP: G5890A102
Event date: 2023-08-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.1200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-220281
- Form type
- SC 13D
- Filer
- Bracebridge Capital, LLC
- CIK
- CIK 1426486
- Filed
- Aug 25, 2023
- Reporting period
- Aug 23, 2023
- Description
- Schedule 13D beneficial ownership